Jim Rotolo is currently the Senior Vice President of Research and Translational Sciences at Sapience Therapeutics, Inc. Prior to this, Jim held various research and leadership roles at ContraFect Corp and Ceramide Therapeutics, LLC. Jim's academic background includes a Ph.D. in Molecular Pharmacology from Cornell University. Jim's work has focused on developing peptide therapeutics for high mortality cancers and targeting the ceramide signaling pathway for medical radiation countermeasures and autoimmune indications.
January, 2023 - present
December, 2020
December, 2018
June, 2016
Chief Scientific Officer at Biomemory
SVP for Research at Penn State University
Chief Behavioral Science Officer And President Americas at Mind Gym
Chief Research & Development Officer at Fate Therapeutics
President & Chief Science Officer at NULASTIN
Access the worlds's biggest network of public org charts
Learn more